candesartan cilexetil and cyclic gmp

candesartan cilexetil has been researched along with cyclic gmp in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukai, D; Kinoshita, M; Maeda, Y; Tsutamoto, T; Wada, A	1
Kinoshita, M; Wada, A	1
Fujii, M; Hayashi, M; Kinoshita, M; Mabuchi, N; Maeda, K; Matsumoto, T; Ohnishi, M; Sawaki, M; Tsutamoto, T; Tsutsui, T; Wada, A	1

Trials

1 trial(s) available for candesartan cilexetil and cyclic gmp

Article	Year
Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. Journal of the American College of Cardiology, 2000, Mar-01, Volume: 35, Issue:3 Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cell Adhesion Molecules; Cyclic GMP; Female; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Natriuretic Peptide, Brain; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke Volume; Tetrazoles; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1	2000

Article

Year

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure.

Journal of the American College of Cardiology, 2000, Mar-01, Volume: 35, Issue:3

Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cell Adhesion Molecules; Cyclic GMP; Female; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Natriuretic Peptide, Brain; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke Volume; Tetrazoles; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1

2000

Other Studies

2 other study(ies) available for candesartan cilexetil and cyclic gmp

Article	Year
Chronic effects of ANG II antagonist in heart failure: improvement of cGMP generation from ANP. The American journal of physiology, 1997, Volume: 272, Issue:5 Pt 2 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Cyclic GMP; Dogs; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Kidney; Male; Norepinephrine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Vascular Resistance	1997
A functional role for endogenous atrial natriuretic peptide in the maintenance of body fluid balance in heart failure. Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:2 Topics: Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Cyclic GMP; Disease Models, Animal; Dogs; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Polysaccharides; Receptors, Atrial Natriuretic Factor; Renin-Angiotensin System; Tetrazoles; Water-Electrolyte Balance	1998

Article

Year

Chronic effects of ANG II antagonist in heart failure: improvement of cGMP generation from ANP.

The American journal of physiology, 1997, Volume: 272, Issue:5 Pt 2

Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Cyclic GMP; Dogs; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Kidney; Male; Norepinephrine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Vascular Resistance

1997

A functional role for endogenous atrial natriuretic peptide in the maintenance of body fluid balance in heart failure.

Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:2

Topics: Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Cyclic GMP; Disease Models, Animal; Dogs; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Polysaccharides; Receptors, Atrial Natriuretic Factor; Renin-Angiotensin System; Tetrazoles; Water-Electrolyte Balance

1998